Related Experiment Video

Updated: Apr 15, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.7K

Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells

Veli Çıtışlı1, Yavuz Dodurga2, Canan Eroğlu3

  • 1Department of Neurosurgery, Pamukkale University School of Medicine, Denizli, Turkey.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|April 4, 2015
PubMed

Insights

Temozolomide (TMZ) effectively combats neuroblastoma cells by inducing apoptosis and inhibiting cell cycle progression, invasion, and colony formation. This alkylating drug shows promise as a single agent or in combination therapy for neuroblastoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Temozolomide (TMZ) is an alkylating agent commonly used in glioma treatment.
  • TMZ functions by inducing apoptosis in cancer cells.

Purpose of the Study:

  • To investigate the anticancer mechanisms of TMZ in the SH-SY5Y human neuroblastoma cell line.
  • To evaluate the effects of TMZ on gene expression, apoptosis, cell cycle, invasion, and colony formation.

Main Methods:

  • XTT assay for cytotoxicity and IC50 determination.
  • Real-time PCR for gene expression analysis (URG4/URGCP, CCND1, CCND2, CDK4, BCL2).
  • TUNEL assay for apoptosis, Matrigel invasion chamber assay for invasion, and colony formation assay.

Main Results:

  • TMZ exhibited cytotoxic effects with an IC50 of 5 mM in SH-SY5Y cells.
  • TMZ significantly decreased the expression of URG4/URGCP, CCND1, CCND2, CDK4, and BCL2.
  • TMZ markedly induced apoptosis and suppressed invasion and colony formation in SH-SY5Y cells.

Conclusions:

  • TMZ demonstrates anticarcinogenesis activity in neuroblastoma cells by impacting cell cycle arrest, apoptosis, invasion, and colony formation.
  • TMZ holds potential as an effective therapeutic agent for neuroblastoma, either alone or in combination therapies.
Keywords:
NeuroblastomaSH-SY5Y cellTemozolamideURG4/URGCP

More Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.3K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K